Effect of microglia activation on dopaminergic neuronal injury induced by manganese, and its possible mechanism

Neurotoxicity Research

Volumn 16, Issue 1, 2009, Pages 42-49

  Liu, Mingchao ^a   Cai, Tongjian ^a   Zhao, Fang ^a   Zheng, Gang ^a   Wang, Qiang ^a   Chen, Yaoming ^a   Huang, Chuanshu ^b   Luo, Wenjing ^a   Chen, Jingyuan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopaminergic neuron; Inducible nitric oxide synthase; Interleukin 1 ; Manganese; Microglia; Tumor necrosis factor

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MANGANESE CHLORIDE; MINOCYCLINE; S METHYLPSEUDOTHIOUREA; THIOUREA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; EMBRYO; ENZYME REGULATION; MACROPHAGE; MICROGLIA; NERVE CELL INHIBITION; NERVE CELL NECROSIS; NERVE CELL STIMULATION; NERVE INJURY; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BRAIN; CELL DEATH; CELLS, CULTURED; CHLORIDES; COCULTURE TECHNIQUES; DOPAMINE; ENZYME INHIBITORS; INTERLEUKIN-1BETA; ISOTHIURONIUM; MANGANESE COMPOUNDS; MICROGLIA; MINOCYCLINE; NEURONS; NEUROTOXINS; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE 3-MONOOXYGENASE; UP-REGULATION;

EID: 70349748550     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12640-009-9045-x     Document Type: Article

References (32)

1. Ambrosini E, Aloisi F (2004) Chemokines and glial cells: A complex network in the central nervous system. Neurochem Res 29:1017-1038
2. Anantharam V, Kitazawa M, Wagner J, Kaul S, Kanthasamy AG (2002) Caspase-3-dependent proteolytic cleavage of protein kinase Cdelta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. J Neurosci 22:1738-1751
3. Anantharam V, Kitazawa M, Latchoumycandane C, Kanthasamy A, Kanthasamy AG (2004) Blockade of PKCdelta proteolytic activation by loss of function mutants rescues mesencephalic dopaminergic neurons from methylcyclopentadienyl manganese tricarbonyl (MMT)-induced apoptotic cell death. Ann N Y Acad Sci 1035:271-289
4. Arvin KL, Han BH, Du Y, Lin SZ, Paul SM, Holtzman DM (2002) Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 52:54-61
5. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318:121-134
6. Cai T, Yao T, Li Y, Chen Y, Du K, Chen J, Luo W (2007) Proteasome inhibition is associated with manganese-induced oxidative injury in PC12 cells. Brain Res 1185:359-365
7. Frigo DE, Vigh KA, Struckhoff AP, Elliott S, Beckman BS, Burow ME, McLachlan JA (2005) Xenobiotic-induced TNF-alpha expression and apoptosis through the p38 MAPK signaling pathway. Toxicol Lett 155:227-238
8. Hirata Y, Suzuno H, Tsuruta T, Oh-Hashi K, Kiuchi K (2008) The role of dopamine transporter in selective toxicity of manganese and rotenone. Toxicology 244:249-256
9. Hunter CL, Bachman D, Granholm AC (2004) Minocycline prevents cholinergic loss in a mouse model of Down's syndrome. Ann Neurol 56:675-688
10. Iravani MM, Kashefi K, Mander P, Rose S, Jenner P (2002) Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration. Neuroscience 110:49-58
11. Kato S, Sugimura N, Nakashima K, Nishihara T, Kowashi Y (2005) Actinobacillus actinomycetemcomitans induces apoptosis in human monocytic THP-1 cells. J Med Microbiol 54:293-298
12. Kitazawa M, Wagner JR, Kirby ML, Anantharam V, Kanthasamy AG (2002) Oxidative stress and mitochondrial-mediated apoptosis in dopaminergic cells exposed to methylcyclopentadienyl manganese tricarbonyl. J Pharmacol Exp Ther 302:26-35
13. Lee YB, Nagai A, Kim SU (2002) Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res 69:94-103
14. Li GJ, Zhao Q, Zheng W (2005) Alteration at translational but not transcriptional level of transferrin receptor expression following manganese exposure at the blood-CSF barrier in vitro. Toxicol Appl Pharmacol 205:188-200
15. Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 5:1403-1409
16. Malthankar GV, White BK, Bhushan A, Daniels CK, Rodnick KJ, Lai JC (2004) Differential lowering by manganese treatment of activities of glycolytic and tricarboxylic acid (TCA) cycle enzymes investigated in neuroblastoma and astrocytoma cells is associated with manganese-induced cell death. Neurochem Res 29:709-717
17. Ryu JK, Franciosi S, Sattayaprasert P, Kim SU, McLarnon JG (2004) Minocycline inhibits neuronal death and glial activation induced by beta-amyloid peptide in rat hippocampus. Glia 48:85-90
18. Sagoo P, Chan G, Larkin DF, George AJ (2004) Inflammatory cytokines induce apoptosis of corneal endothelium through nitric oxide. Invest Ophthalmol Vis Sci 45:3964-3973
19. Suk K (2004) Minocycline suppresses hypoxic activation of rodent microglia in culture. Neurosci Lett 366:167-171
20. Tieu K, Ischiropoulos H, Przedborski S (2003) Nitric oxide and reactive oxygen species in Parkinson's disease. IUBMB Life 55:329-335
21. Tomas-Camardiel M, Rite I, Herrera AJ, de Pablos RM, Cano J, Machado A, Venero JL (2004) Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system. Neurobiol Dis 16:190-201
22. van Rossum D, Hanisch UK (2004) Microglia. Metab Brain Dis 19:393-411
23. Vilhardt F (2005) Microglia: Phagocyte and glia cell. Int J Biochem Cell Biol 37:17-21
24. Wada O, Yanagisawa H (1996) Trace elements and their physiological roles. Nippon Rinsho 54:5-11
25. Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, Ferrante RJ, Kristal BS, Friedlander RM (2003) Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Proc Natl Acad Sci USA 100:10483-10487
26. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22:1763-1771
27. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95:15769-15774
28. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96:13496-13500
29. Zeevalk GD, Bernard LP (2005) Energy status, ubiquitin proteasomal function, and oxidative stress during chronic and acute complex I inhibition with rotenone in mesencephalic cultures. Antioxid Redox Signal 7:662-672
30. Zeevalk GD, Bernard LP, Nicklas WJ (1998) Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism. J Neurochem 70:1421-1430
31. Zhang J, Fitsanakis VA, Gu G, Jing D, Ao M, Amarnath V, Montine TJ (2003) Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: A link through mitochondrial dysfunction. J Neurochem 84:336-346
32. Zheng W, Ren S, Graziano JH (1998) Manganese inhibits mitochondrial aconitase: A mechanism of manganese neurotoxicity. Brain Res 799:334-342